 Connection
Paul Bunn to Antigens, Neoplasm
This is a "connection" page, showing publications Paul Bunn has written about Antigens, Neoplasm.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.726 |
|
|
|
-
Peled N, Oton AB, Hirsch FR, Bunn P. MAGE A3 antigen-specific cancer immunotherapeutic. Immunotherapy. 2009 Jan; 1(1):19-25.
Score: 0.258
-
Bunn PA. Molecular biology and early diagnosis in lung cancer. Lung Cancer. 2002 Oct; 38(1):S5-8.
Score: 0.167
-
Longley C, Furmanski P, Dienhart DG, Lear J, Bloedow D, Kasliwal R, Bunn PA. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Cancer Res. 1990 Sep 15; 50(18):5954-61.
Score: 0.073
-
Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984 Aug 03; 72(1):77-89.
Score: 0.048
-
Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 2002 Jul 15; 62(14):3971-9.
Score: 0.041
-
Khorana A, Bunn P, McLaughlin P, Vose J, Stewart C, Czuczman MS. A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma. Leuk Lymphoma. 2001 Mar; 41(1-2):77-87.
Score: 0.037
-
Bunn PA. Immune therapy for lung cancer: are we getting closer? Am J Respir Cell Mol Biol. 1999 Jul; 21(1):10-2.
Score: 0.033
-
Beck LK, Kane MA, Bunn PA. Innovative and future approaches to small cell lung cancer treatment. Semin Oncol. 1988 Jun; 15(3):300-14.
Score: 0.015
-
Fargion S, Carney D, Mulshine J, Rosen S, Bunn P, Jewett P, Cuttitta F, Gazdar A, Minna J. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May; 46(5):2633-8.
Score: 0.013
-
Lindmo T, Boven E, Mitchell JB, Morstyn G, Bunn PA. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody. Cancer Res. 1985 Oct; 45(10):5080-7.
Score: 0.013
-
Minna JD, Cuttitta F, Rosen S, Bunn PA, Carney DN, Gazdar AF, Krasnow S. Methods for production of monoclonal antibodies with specificity for human lung cancer cells. In Vitro. 1981 Dec; 17(12):1058-70.
Score: 0.010
-
Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28; 304(22):1319-23.
Score: 0.010
-
Roth MS, Bunn PA, Foon KA. Interferon therapy for lymphoproliferative disorders. Cancer Treat Res. 1988; 38:231-52.
Score: 0.004
-
Gazdar AF, Bunn PA, Minna JD, Baylin SB. Origin of human small cell lung cancer. Science. 1985 Aug 16; 229(4714):679-80.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|